Canadian governments doubles down on clinical research; BMS cited for another monkey death;

 @FierceBiotech: Frog skin secretions: icky but potent new anti-bacterials? Story | Follow @FierceBiotech

 @JohnCFierce: Virtual is beautiful in biotech. Piece | Follow @JohnCFierce

 @RyanMFierce: U.K. researchers are forging ahead with a pioneering trial for gene therapy to treat cystic fibrosis. News | Follow @RyanMFierce

@FierceMedDev: Japan's scandal-hit Olympus to launch new medical devices. More via @Reuters | Follow @FierceMedDev

> The Canadian government plans to pump twice as much money into clinical research over the next 5 years as part of its tie-up with the pharmaceutical industry to boost clinical trials and other biopharma activity in the country. The industry group Rx&D is expected to match the government's $150 million (Canadian) investment. Article

> Xconomy reports that growth in venture-backed biotech company valuations lags the increase in value of tech startups in Silicon Valley. Report

> According to reports on Twitter, an FDA advisory committee has voted 11-2 in favor of recommending approval of GlaxoSmithKline's ($GSK) cancer drug Votrient (previously approved to treat kidney cancer) as a remedy against soft tissue sarcoma.

> The USDA has slapped Bristol-Myers Squibb ($BMY) for allowing a research monkey to die at one of its facilities. The biopharmaceutical company was cited for a monkey death last year as well. Report

Pharma News

 @FiercePharma: Antioxidants may not help people with Alzheimer's. Article via @Reuters | Follow @FiercePharma

> Bayer, others fined $15.9M by Romanian competition authority. More

> Indian government defends country's generics industry. News

> Groups urge FTC to investigate vaccine 'bundling'. Story

> Eisai eyes job creation in U.K. with facility ops expansion. Item

Manufacturing News

> Sandoz's role in Canadian drug shortages adds to calls for regulation. More

> FDA says APP ignored consumer complaints for 18 months. Story

> Apotex says FDA import ban, delays 'decimated' its business. Item

Biotech Research News

> Mayo Clinic concocts skin cancer vaccine using virus, melanoma DNA. Article

> Ban on animal importation puts U.K. research at risk. Item

> Latest anti-RAGE compound defeats Alzheimer's symptoms in mice. Story

> RNAi, smuggled in a virus, weakens tumors before final radiation blow. More

> Columbia University team re-creates full human immune system in mice. Story

And Finally… Allan Cohen, lead counsel at Celtic Pharma, says that the biopharma industry needs a blockbuster success to come from the ranks of virtual developers before the virtual model takes off. Article

Suggested Articles

Werewolf is launching with $56 million and an approach that can cut through the toxic effects that have limited certain cancer-killing agents.

As Relay looks to enter the clinic in 2020, the company is adding a trio of biopharma vets to its leadership team.

A phase 3 trial of Myovant Sciences’ relugolix in prostate cancer has met its primary endpoint, teeing the company up to file for FDA approval.